These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10910940)

  • 1. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.
    Carter AM; Catto AJ; Kohler HP; Ariëns RA; Stickland MH; Grant PJ
    Blood; 2000 Aug; 96(3):1177-9. PubMed ID: 10910940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study.
    Rasmussen-Torvik LJ; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Rosamond WD; Folsom AR
    Thromb Res; 2007; 121(1):1-7. PubMed ID: 17433418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
    Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
    Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation.
    Carter AM; Catto AJ; Grant PJ
    Circulation; 1999 May; 99(18):2423-6. PubMed ID: 10318664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and alpha-fibrinogen Thr312Ala allele: case report.
    Cieśla-Dul M; Gaweda B; Wypasek E; Rózańska M; Sadowski J
    Pol Arch Med Wewn; 2009 Dec; 119(12):822-5. PubMed ID: 20010469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance.
    Li JF; Lin Y; Yang YH; Gan HL; Liang Y; Liu J; Yang SQ; Zhang WJ; Cui N; Zhao L; Zhai ZG; Wang J; Wang C
    PLoS One; 2013; 8(7):e69635. PubMed ID: 23894515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factor XIII-A subunit Val34Leu polymorphism and risk of venous thromboembolism in young adults].
    Demyanenko AV; Kapustin SI; Soroka VV; Chechulov PV
    Angiol Sosud Khir; 2015; 21(2):21-5. PubMed ID: 26035561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.
    Marín F; Corral J; Roldán V; González-Conejero R; del Rey ML; Sogorb F; Lip GY; Vicente V
    J Mol Cell Cardiol; 2004 Sep; 37(3):699-704. PubMed ID: 15350843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
    Bereczky Z; Balogh E; Katona E; Pocsai Z; Czuriga I; Széles G; Kárpáti L; Adány R; Edes I; Muszbek L
    Thromb Res; 2007; 120(4):567-73. PubMed ID: 17250879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between pulmonary embolism or deep vein thrombosis and the -455G/A beta-fibrinogen gene polymorphism.
    Camilleri RS; Cohen H
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):193-8. PubMed ID: 15795538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII Val34Leu polymorphism and gamma-chain cross-linking at the site of microvascular injury in healthy and coumadin-treated subjects.
    Undas A; Brzezinska-Kolarz B; Brummel-Ziedins K; Musial J; Szczeklik A; Mann KG
    J Thromb Haemost; 2005 Sep; 3(9):2015-21. PubMed ID: 16102108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen β chain and FXIII polymorphisms affect fibrin clot properties in acute pulmonary embolism.
    Klajmon A; Chmiel J; Ząbczyk M; Pociask E; Wypasek E; Malinowski KP; Undas A; Natorska J
    Eur J Clin Invest; 2022 Apr; 52(4):e13718. PubMed ID: 34783023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Goldsmith K; van Marion V; Long L; Treacy CM; Dudbridge F; Toshner MR; Pepke-Zaba J; Eikenboom JC; Morrell NW
    Eur Respir J; 2008 Apr; 31(4):736-41. PubMed ID: 18057060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
    Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
    Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
    Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
    Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.